Government-backed Heal-Covid trial finds Apixaban, given in severe cases, can cause dangerous bleeding and does not improve prognosis
A blood-thinning drug given as a potential life-saver to many patients recovering from severe Covid does not work and can cause major bleeding, new research shows.
The findings have led to calls for doctors to stop advising people to take Apixaban, because it does not stop them from dying or ending up back in hospital and also can have serious side-effects.
